Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment
- PMID: 9254089
- DOI: 10.3171/jns.1997.87.2.0252
Absence of bleeding complications in patients undergoing cortical surgery while receiving valproate treatment
Abstract
Valproate (VPA) is associated with a variety of idiosyncratic hematological effects including thrombocytopenia, inhibition of platelet aggregation, and fibrinogen depletion. This has led some investigators to recommend discontinuation of VPA therapy prior to elective surgical procedures. However, administration of VPA therapy is not altered prior to surgery at the authors' center and no VPA-associated bleeding complications have been observed. Therefore, a retrospective chart review was conducted to verify the clinical observations in patients who had undergone cortical resection while receiving antiepileptic drugs (AEDs). Baseline, surgical, and postoperative laboratory data were available for a total of 313 patients, 111 of whom were receiving VPA and 202 of whom were receiving AEDs without VPA (control patients). Eighty-seven percent of the patients receiving VPA were also being treated with at least one other AED. The control group was approximately equally divided between monotherapy (55%) and polytherapy (45%) treatments. Platelet counts were significantly lower in the control polytherapy (284 +/- 74 x 10(9)/L) and both VPA groups (279 +/- 113 x 10(9)/L) as compared with the control monotherapy group (314 +/- 85 x 10(9)/L). Baseline fibrinogen levels were significantly lower in the VPA than in the control groups (223 +/- 91 g/dl vs. 278 +/- 95 g/dl). Both pre- and postoperatively, the VPA group had lower red blood cells counts, hematocrit, and hemoglobin levels. There was no significant difference between groups in estimated blood loss during surgery or qualitative wound discharge postsurgery. There was only one case of a bleeding complication, which occurred 14 days postoperatively in a patient receiving carbamazepine monotherapy. The results of this study confirm the clinical observations of an absence of bleeding complications in patients receiving VPA therapy at the time of surgery, despite differences in laboratory parameters.
Similar articles
-
Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.Clin Neurol Neurosurg. 2010 May;112(4):291-5. doi: 10.1016/j.clineuro.2009.12.014. Epub 2010 Jan 13. Clin Neurol Neurosurg. 2010. PMID: 20071075
-
Preoperative valproate administration does not increase blood loss during temporal lobectomy.Epilepsia. 1996 Jan;37(1):98-101. doi: 10.1111/j.1528-1157.1996.tb00519.x. Epilepsia. 1996. PMID: 8603633
-
No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.J Pharm Pharmacol. 2011 Jul;63(7):976-81. doi: 10.1111/j.2042-7158.2011.01282.x. J Pharm Pharmacol. 2011. PMID: 21635265
-
Sodium valproate, platelet dysfunction, and bleeding.Epilepsia. 1981 Apr;22(2):141-6. doi: 10.1111/j.1528-1157.1981.tb04094.x. Epilepsia. 1981. PMID: 6781890 Review.
-
Valproate-induced reversible cognitive decline presenting as dementia and associated clinical features: A literature review.Seizure. 2023 Oct;111:45-50. doi: 10.1016/j.seizure.2023.07.018. Epub 2023 Jul 25. Seizure. 2023. PMID: 37515866 Review.
Cited by
-
Valproic acid in epilepsy : pregnancy-related issues.Drug Saf. 2006;29(1):1-21. doi: 10.2165/00002018-200629010-00001. Drug Saf. 2006. PMID: 16454531 Review.
-
[Status epilepticus].Nervenarzt. 2012 Feb;83(2):187-94. doi: 10.1007/s00115-011-3337-0. Nervenarzt. 2012. PMID: 22249602 German.
-
Valproate as a mainstay of therapy for pediatric epilepsy.Paediatr Drugs. 2006;8(2):113-29. doi: 10.2165/00148581-200608020-00004. Paediatr Drugs. 2006. PMID: 16608372 Review.
-
Assessment of need for hemostatic evaluation in patients taking valproic acid: A retrospective cross-sectional study.PLoS One. 2022 Feb 25;17(2):e0264351. doi: 10.1371/journal.pone.0264351. eCollection 2022. PLoS One. 2022. PMID: 35213601 Free PMC article.
-
Analytical Method Development for Sodium Valproate through Chemical Derivatization.Int J Anal Chem. 2020 Jan 31;2020:5672183. doi: 10.1155/2020/5672183. eCollection 2020. Int J Anal Chem. 2020. PMID: 32099545 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical